Concepedia

Ervin R. Spitzmiller

ER

Statistics

Publications

12

Citations

419

H-Index

11

Active since

1947

Affiliations

Institute for Medical Research(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Sweden)

Ervin R. Spitzmiller is an author at Institute for Medical Research specializing in pharmacology, natural sciences, and drug discovery.

Top concepts

Publications per year

1947–1994

12

Publications

12

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines

John Krapcho, Chester F. Turk, David W. Cushman et al. · Journal of Medicinal Chemistry · 1988 · 163 citations · Full text

, , +18

Substituted 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones and 3,4-Dihydro-2-phenyl-(2H)-1,6-benzothiazocin-5(6H)-ones

John Krapcho, Ervin R. Spitzmiller, Chester F. Turk · Journal of Medicinal Chemistry · 1963 · 71 citations

, , +15

Synthesis of 2-phosphonopyrrolidine and its substitution for proline in an inhibitor of angiotensin-converting enzyme

Edward W. Petrillo, Ervin R. Spitzmiller · Tetrahedron Letters · 1979 · 43 citations

, , +8

Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonists

Denis E. Ryono, John Lloyd, Michael A. Poss et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 24 citations

, , +4

3,5‐Disubstituted‐1,2,4‐oxadiazoles and 4,5‐dihydro‐3,5‐disubstituted‐1,2,4‐oxadiazoles

Harry L. Yale, Ervin R. Spitzmiller · Journal of Heterocyclic Chemistry · 1978 · 20 citations

, , +9

1–5 of 12